Indian CRO taps ArisGlobal to up delivery capabilities

SIRO Clinpharm is in “a new area of growth” following the procurement of ArisGlobal’s LifeSphere Clinical platform, which has enabled the company to expand its business prospects, says CRO.

SIRO Clinpharm is a full-service contract research organization (CRO) headquartered in Maharashtra, India.

US-based ArisGlobal’s LifeSphere Clinical platform includes a unified, integrated CTMS and EDC solution, LifeSphere CTMS for Clinical Trial Management, and LifeSphere EDC for Clinical Data Management.

According to SIRO, the platform provides “a comprehensive, versatile and end-to-end clinical research solution” to its clients.

A company representative told us in a comment that the platform enables SIRO meet database go-live timelines by at least seven working days in advance, “which in turn helps sponsors start and thereby execute a study ahead of pre-determined timelines.”

These platforms are highly cost effective and give a competitive advantage to our company in terms of delivering a high quality product to our clients within the shortest timeframes,” they said.

This is a new area of growth wherein the growth of LifeSphere has directly benefited in gaining more business prospects for SIRO.”